Current calls, week 50, 2021
Tips from KI Grants Office about current calls.
Swedish and Nordic calls
Student Degree Project Grant Programme – SRP Diabetes
SRP Diabetes supports principal investigators planning to supervise a student in an educational program at KI (e.g. medical students, biomedicine program, master programmes) while the student performs his/her degree project work. Projects should be in the area of diabetes and/or metabolism.
Closing date:16 January 2022
Working environment project grants – Nordic Council of Ministers
These support research projects that promote a common Nordic experience and knowledge base for further development and modernisation of the working environment policy and administration in the Nordic countries. The total budget is worth DKK 2 million.
Closing date:1 February 2022
Post doc grants – Swedish Research Council for Health, Working Life and Welfare (Forte)
Forte’s annual call for postdoc grants aims to support competence and career development for junior researchers and to promote research mobility. The call is open to applications within Forte’s overall areas of responsibility: health, working life and welfare. The purpose of the call is to enable analysis of and contribute to an in-depth knowledge within defined research areas or issues. In total, around SEK 50 million is reserved for the period 2023-2024. Three types of grants are available within this call:
- National postdoc grant - National postdoc grants are intended for researchers in Sweden who want to carry out their postdoc in Sweden.
- International postdoc, Incoming - Incoming postdoc grants are intended for researchers abroad who wants to spend their postdoc period in Sweden.
- International postdoc, Outgoing - Outgoing postdoc grants are meant for researchers in Sweden who wish to spend their postdoc period abroad.
Closing date: 24 February 2022
EXTENDED DEADLINE: ESPID/INOPSU infection surveillance research grant - European Society for Paediatric Infectious Diseases
*** The closing date for this opportunity has been extended. The previous deadline of 1 March has been extended to 31 December 2021. All other call details remain unchanged. ***
The European Society for Paediatric Infectious Diseases and the International Network of Paediatric Surveillance Units invites applications for their infection surveillance research grant. This supports infection surveillance across two or more European countries and aims to facilitate infection surveillance research in Europe.
Applicants should be ESPID members in good standing. Applicants who have not previously received substantial research funding will be favoured. Projects must be directly relevant to paediatric infectious diseases. Applications should come from areas of Europe where there is currently little or no such work going on.
The grant covers administrative costs of the surveillance units, and a small amount of essential consumables of up to €20,000.
Closing date: 31 December 2021
Congenital adrenal hyperplasia grant - European Society for Paediatric Endocrinology
The European Society for Paediatric Endocrinology and the International Fund raising for Congenital Adrenal Hyperplasia invite letters of intent for their congenital adrenal hyperplasia grant. This supports research on congenital adrenal hyperplasia. Specific goals include:
•increasing knowledge on pathophysiology of the disease;
•prevention, diagnostic and treatment of natural or iatrogenic complications;
•proposition of new therapeutic targets and protocols.
Applicants must hold an MD, PhD or equivalent academic degree, and have a faculty position or equivalent at a college, university, medical school or comparable institution. Only one project per research team will be considered. Participation is open worldwide and should, if possible, include teams based in Europe.
The total budget is €350,000. Grants are worth up to €150,000 each over three years to cover expenses directly linked to the project, including specific equipment, operating costs or salaries of co-workers.
Closing date:15 January 2022 (Forecast)
COVID-19 response open call - Digital Innovation Hub Healthcare Robotics
The Digital Innovation Hub Healthcare Robotics invites proposals for its COVID-19 response open call. This accelerates the embedding of robotic applications in healthcare-related settings and enables the smooth deployment of new, effective robotic-based solutions. Proposals must clearly state the relevant clinical demand and the healthcare problem related to COVID-19 to be solved by the robotic application, as well as the added clinical value of the solution. It must be an already existing robotic system that is at technology readiness levels 7 to 8.
Consortia must include at least one SME or slightly larger company and four end-users from four different EU member states, associated countries or European Economic Area countries.
Eight grants worth up to €250,000 each over nine months are available.
Closing date:15 January 2022
Call for research proposals on radiofrequencies and health - French Agency for Food, Environmental and Occupational Health and Safety |
The French Agency for Food, Environmental and Occupational Health and Safety, under its national research programme for environmental and occupational health, invites letters of intent for its call for research proposals on radiofrequencies and health. This supports research projects that aim to evaluate or analyse the health risks associated with radiofrequencies, in the context of the general population and the workplace. The priority research themes are:
•mechanisms of action at the cellular level;
•physiological and health effects of radiofrequencies;
•hypersensitivity to electromagnetism;
•types of exposure.
Research teams belonging to any institution may apply. Non-research-oriented partners are permitted as long as their added value in the project has clearly been established. Proposals submitted by a French team may include a partnership with one or more foreign teams. Proposals submitted by a foreign team or a team that belongs to an international organisation must include a French academic partner.
Two types of proposal are eligible:
•feasibility studies, worth up to €50,000 over two years;
•complete projects, worth between €40,000 and €300,000 over two to three years.
Closing date:18 January 2022
Research grants - European Society of Cardiology
The European Society of Cardiology invites applications for its research grants. These enable members to undertake specialised cardiovascular research or further training in the field in an ESC regular member country. The goal is to help young candidates obtain research experience in a high standard academic centre, enabling them to contribute to the improvement of academic standards. Preference is given to applicants in countries or regions where modern clinical cardiology is not yet strong, provided that the applicant can contribute to the improvement of clinical cardiology upon their return.
Applicants must be below 40 years of age and be citizens or permanent residents of an ESC member or affiliated member country throughout the three years preceding the application date. Periods of residence dedicated to full-time education are not accepted as ordinary residence. They must hold a PhD or DPhil degree or equivalent, or must have submitted a thesis before taking up the fellowship. Medical graduates may apply if they have completed their basic professional training and are able to demonstrate their expertise through abstract presentation at a national or international meeting, or have published a paper in a relevant journal. Applicants must be members of the ESC. Applicants are allowed to apply to an institution based in their own country, provided it is not their home institution.
Grants are worth €25,000 each per year for projects lasting between three months and one year.
Closing date: 31 January 2022
EFSD/Lilly young investigator research awards - European Association for the Study of Diabetes
The European Foundation for the Study of Diabetes and Lilly invite applications for their young investigator research awards. These encourage innovative research in the field of diabetes and its complications, and promote excellence in medical education.
Applicants must be paid-up members of EASD and must have received their highest degree no more than five years ago for basic scientists, or seven years ago for clinicians on 1 January 2022. For clinicians holding more than one qualifying degree or with a clinical specialist degree, the time since the first degree must be no more than 10 years before January 1 2022. Research awards must be held at a non-profit institution based in Europe or an associated country.
Awards are worth €50,000 each.
Closing date:15 February 2022
Federal Funding agencies
Notice of Intent to Publish a Funding Opportunity Announcement for Advancing Research on Mechanisms and Management of Pain for Diseases and Conditions within NIDDK Mission Areas (R01 Clinical Trial Optional): NIH
The purpose of this Notice is to inform the community that the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) intends to publish a Funding Opportunity Announcement (FOA) that will invite broad investigator-initiated research projects proposing novel basic, translational, and clinical studies and efforts to develop new approaches to assess and treat pain for disorders within the NIDDK mission areas.
This upcoming FOA is expected to be published in the Winter of 2022 with an expected application due date in the Spring 2022. It will utilize the Research Project Grant (R01 Clinical Trial Optional) mechanism.
This Notice is provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive projects. This will be an open competition.
Notice of Special Interest (NOSI): Epidemiology and Prevention of Alcohol Misuse in Understudied Young Adult Populations; Military, Workforce, and Community College: NIH
The purpose of this future grant application solicitation is to balance the NIAAA research portfolio by supporting research on alcohol misuse among persons aged 18 to 29 who are not enrolled in four-year colleges or universities. These persons are commonly in the military, workforce, or community college populations, which are understudied relative to their age peers in four-year colleges. Research on epidemiology, prevention, and screening centered on these understudied populations are all encouraged.
Notice of Special Interest (NOSI): Methods Development for Genomic Studies of Genetic Variation, Function, and Disease: NIH
The National Human Genome Research Institute (NHGRI) is issuing this Notice of Special Interest (NOSI) to encourage applications that develop novel computational or experimental approaches for genomic studies of how genetic variants relate to genomic function, phenotype, and disease.
Transformative Nucleic Acid Sequencing Technology Innovation and Early Development (R21 Clinical Trial not Allowed): NIH
This Funding Opportunity Announcement (FOA) solicits R21 grant applications to innovate and develop the early stages of novel technologies that will enable greater than a one order of magnitude improvement in 1) DNA sequencing, and 2) methods for direct sequencing of the diversity of entire RNA molecules. Advances in genomics and more broadly in biomedical research have been greatly facilitated by cycles of technology innovation and disruption that have driven significant and sustained nucleic acid sequencing throughput and assembly quality increases combined with cost decreases and read quality improvements. The goal now is to dramatically advance DNA sequencing and direct RNA sequencing technologies at reasonable costs with the anticipation that significant exploratory innovation in any of these and related areas would make significant contributions to the mission of NHGRI and the field of genomics, including to many of NHGRI’s other technology development goals.
Closing date: March 1, 2022; February 1, 2023.
Funding Opportunity Announcement (FOA): RFA-HG-21-007
This funding opportunity announcement (FOA) encourages applications for research in cancer control and population sciences. The overarching goal is to provide support to promote research efforts on novel scientific ideas that have the potential to substantially advance cancer research in statistical and analytic methods, epidemiology, cancer survivorship, cancer-related behaviors and behavioral interventions, health care delivery, and implementation science.
Closing date: March 07, 2022, November 08, 2022, March 07, 2023, November 05, 2023, March 07, 2024.
Funding Opportunity Announcement (FOA): PAR-21-190
Cutting-Edge Basic Research Awards (CEBRA) (R21 Clinical Trial Optional): NIH
The National Institute on Drug Abuse (NIDA) Cutting-Edge Basic Research Award (CEBRA) is designed to foster highly innovative or conceptually creative research related to the etiology, pathophysiology, prevention, or treatment of substance use disorders (SUDs). It supports high-risk and potentially high-impact research that is underrepresented or not included in NIDA's current portfolio that has the potential to transform SUD research. The proposed research should: 1. develop, and/or adapt, revolutionary techniques or methods for addiction research or that show promising future applicability to SUD research; and /or 2. test an innovative and significant hypothesis for which there are scant precedent or preliminary data and which, if confirmed, would transform current thinking.
Closing date: March 8, 2022, August 10, 2022, March 8, 2023, August 10, 2023, March 8, 2024.
Funding Opportunity Announcement (FOA): PAR-21-208
Clinical Relevance of the Linkage between Environmental Toxicant Exposures and Alzheimer’s Disease and Related Dementias (R01 Clinical Trial Not Allowed): NIH
This Funding Opportunity Announcement (FOA) supports mechanistic and early translational research focused on a more rigorous in-depth examination of the potential interactions of environmental toxins with genetic and non-genetic molecular targets known to influence Alzheimer's Disease and Alzheimer's Disease Related Dementias (AD/ADRD). It is expected that these studies will address the clinical relevance of these exposures on disease initiation, progression, or modification. Anticipated outcomes include an improved understanding of neurological mechanisms of chemical toxicities related to AD/ADRD, more evidence-based potential biomarkers of exposure and toxicity for those most at risk, as well as more data to support causality and potential approaches for mitigation. The scope of research includes mechanistic studies on the modification of known AD/ADRD targets by neurotoxins of concern, and conversely, whether known targets for these neurotoxins play a role in etiologies of AD/ADRD. The development and validation of neuropathological, neurophysiological and neurobehavioral animal models that simulate potential toxin exposures in humans is another example of supported studies. Preclinical studies of interactions of environmental toxicant with AD/ADRD in pilot human subject studies (that do not meet the NIH definition of clinical trial) are appropriate for this FOA. Interdisciplinary collaboration is required to address the various fields of study related to this research, e.g., neuroscience, aging, and environmental health sciences.
Closing date: March 11, 2022
Funding Opportunity Announcement (FOA): PAR-22-048
Walter Katkovsky research grants - American Psychological Association, US
The American Psychological Association invites applications for the Walter Katkovsky research grants. These support research on the general topic of psychotherapy. Research proposals should be directed to questions and hypotheses designed to improve understanding based on theory or methods of how psychotherapy promotes behavioural, emotional, or cognitive changes.
Applicants must have up to 12 years of postdoctoral experience and be affiliated with a non-profit charitable, educational or scientific institution, or government entity operating exclusively for charitable and educational purposes.
Grants are worth up to USD 20,000 each.
Closing date: March 1, 2022.
Standard Research Grant - Scoliosis Research Society, US
The Scoliosis Research Society invites applications for its standard research grant. This supports research in the area of spinal deformities.
Applicants do not need to be members of the SRS but do need to have at least one SRS member as co-investigator. Research for independent manufacturers, industry development or personal business financial gain will not be supported.
The grant is worth up to USD 37,500 per year for a maximum period of two years.
Closing date: Letters of Intent Collected*: February 1 - March 15 (11:59pm EST)
*Applicable to: Biedermann Innovation Award, New Investigator Grant, SRS-Cotrel Foundation Basic Science Grant, and Standard Research Grants
Application for Resident/Fellow Grants and Exploratory Micro-Grants Collected: February 1 - March 15 (11:59pm EST)
Requests for Full Proposals: No later than April 15
Full Proposal Applications Open: April 15 - May 15
Award Notifications: August